Detalles de la búsqueda
1.
Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity.
Mol Cancer Ther
; 19(4): 988-998, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32241872
2.
IMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptor.
Clin Cancer Res
; 13(18 Pt 2): 5549s-5555s, 2007 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17875788
3.
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054.
J Immunother Cancer
; 6(1): 45, 2018 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29866166
4.
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054.
J Immunother Cancer
; 6(1): 31, 2018 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29712568
5.
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Cancer Res
; 63(24): 8912-21, 2003 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14695208
6.
A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation.
MAbs
; 7(5): 931-45, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26073904
7.
Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed.
Hum Antibodies
; 13(3): 81-90, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15598988
8.
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.
Cancer Biol Ther
; 15(9): 1208-18, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24921944
9.
IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab.
Hum Antibodies
; 19(4): 89-99, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21178280
10.
Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
Clin Cancer Res
; 16(4): 1191-205, 2010 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20145179
11.
Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis.
Cancer Immunol Immunother
; 56(3): 343-57, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16832681
12.
Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.
J Biol Chem
; 279(4): 2856-65, 2004 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-14576153
Resultados
1 -
12
de 12
1
Próxima >
>>